Conclusions:
Decreased perfusion and hypoxia have been observed both in human and experimental OA bone. This study demonstrates that hypoxia activates the fibrinolytic pathway in human OA osteocytes resulting in increased plasmin generation but reveals a defective response in PAI-1. The lack of PAI-1 expression in OA osteocytes is at variance with increases in PAI-1 by Purpose: Traumatic joint injury damages cartilage and releases inflammatory cytokines from adjacent joint tissues, increasing the risk of developing osteoarthritis. Previously, we reported that mechanical injury increased the catabolic effects of TNF-α in immature bovine and adult human articular cartilage, and that endogenous IL-6 played a role in proteoglycan loss caused by injury+TNF-α treatment. Glucocorticoids such as dexamethasone can inhibit expression of inflammatory genes. In this study we hypothesized that the combination of mechanical injury and TNF-α would up-regulate expression of proteins involved in catabolic and inflammatory processes, and that short-term dexamethasone treatment would prevent cartilage degradation by suppressing the production of matrix-degrading enzymes and cytokines. Methods: Cartilage disks (3 mm diam., 1 mm thick) were harvested from the middle zone of the femoropatellar grooves of 1-2-week old calves. Location-matched disks were either injuriously compressed (50% strain, 100%/second strain rate) or maintained free-swelling, cultured in medium with or without rhTNF-α (25 ng/ml), and in the presence or absence of dexamethasone (10nM). Culture was terminated after 6 days of treatment. DMMB dye was used to quantify sGAG released into the medium. Disks were radiolabeled during days 4-6 with 5 μCi/ml 35 SO -2 4 and 10 μCi/ml 3 H-proline to assess proteoglycan and total protein synthesis. In parallel tests, cartilage disks from 6 animals were flash-frozen after 4 days of treatment. RNA was extracted, reverse transcribed and the mRNA levels for 24 genes of interest (proteases, matrix molecules, cytokines, growth and transcription factors) were measured using qPCR (ABI 7900HT). Within each condition, RNA copy numbers of each gene were normalized to that of 18S from the same condition. To examine the effects of treatments, each gene was normalized to its level in the notreatment control. Statistical analysis was performed using a linear mixed-effect model, followed by Tukey's pairwise comparison.
Results:
The combination of TNF-α+injury up-regulated the expression of ADAMTS-4,-5, MMP-3,-9,-13, TIMP-3, iNOS, Caspase-3 and IL-6 (Fig.1, *p<0 .05 vs. no-treatment control). TNF-α, with or without injury, significantly increased GAG loss (Fig. 2 , *p<0.05) and decreased chondrocyte biosynthesis (data not shown). However, the catabolic effects of TNF-α and TNFα+injury were abolished in the presence of dexamethasone: both proteoglycan loss and biosynthesis remained at the levels similar to no-treatment controls (Fig. 2) . Conclusions: Mechanical injury potentiated the catabolic response induced by TNF-α at the transcript level (data not shown). Short term glucocorticoid treatment effectively abolished the catabolic effects of TNF-α plus injury, preventing both proteoglycan degradation and biosynthesis reduction. Ongoing studies focus on identifying the effects of dexamethasone on expression of inflammatory cytokines and enzymes at the transcript level. Methods: Tissue engineered (TE) cartilage was prepared by using silk-derived porous 3D scaffolds seeded with primary human chondrocytes and culturing in chondrogenic medium for 4 weeks. The TE cartilage mimicked cartilage in terms of many aspects of cell and matrix features. An osteoarthritis-like phenotype was induced by culturing the cells with cytokines, a combination of IL-1β, and TNF-α, or culturing the cells with conditioned medium from THP-1 derived macrophages. The later served to generate a broad spectrum of cytokines to represent the infiltration of macrophages in vivo. The systems were studied for up to 5 weeks in a static culture. Results: After 1 week with cytokines induction, matrix anabolismrelated genes such as ACAN (GAG) and Col II were dramatically down-regulated; while at the same time genes for matrix catabolism-related enzymes, such as MMP13, ADAMTS4, were up-regulated. As a marker of aging and calcification in osteoarthritis, the Col X gene was up-regulated 7-fold when compared to the untreated (control) group. The data indicated that chondrocytes responded to the cytokine stimulation in these 3D cultures and matrix turnover was initiated, in as a mimic of the disease condition. After 3 weeks, chondrocyte apoptosis was found in the TE cartilage, with a higher or dose response effect when the TE cartilage system was treated with a higher dose of cytokines. Collagen type X expression was confirmed by immunohistology. For TE cartilage treated with conditioned medium from the macrophages, the results and trends were similar to those with the cytokine treated group, except for some differences in magnitude of response in matrix-related gene expression. This difference may due to the complex components present in this conditioned media besides IL-1β and TNF-α. Conclusions: Silk porous scaffolds provided a compatible environment for three-dimensional tissue engineered cartilage. In the presence of cytokines or conditioned medium from macrophages, TE cartilage showed osteoarthritis-like phenotypes, with results generally consistent with previous clinical studies. This approach may serve as a suitable starting point to generate relevant and useful in vitro osteoarthritis models. Purpose: Alkaptonuria (AKU) is a rare autosomal recessive condition resulting from lack of homogentisate 1,2 dioxygenase (HGD), the enzyme responsible for the breakdown of homogentisic acid (HGA). HGA accumulates in body tissues resulting in ochronosis, the deposition of pigmented HGA polymers that have high affinity for collagenous tissues, primarily articular cartilage of the weight bearing joints. Over time, pigmentation leads to severe joint degeneration presenting as osteoarthritis. The aim of this study was to use light and transmission electron microscopy (TEM) to identify the location of ochronotic pigment in joint tissues in vivo and in an in vitro model. Methods: Tissues were collected at the time of surgery from AKU patients undergoing joint surgery. C20-A4 transformed human chondrocytes and SaOS-2 osteosarcoma cells were cultured in DMEM in the presence or absence of 0.33×10 -4 M HGA. All samples were processed routinely for histology and TEM. Paraffin sections were stained with either H&E or nuclear fast red and Schmorl's reagent to highlight pigment. TEM samples were post stained using uranyl acetate and lead citrate. Results: Macroscopic examination of AKU tissues revealed intense pigmentation of articular cartilage. Synovial and capsular tissues had pigmented and non-pigmented areas. Bone was almost devoid of pigmentation. H&E staining of surgical tissues demonstrated pigment intra-and extracellularly. Chondrocytes, fibroblasts and osteocytes all contained pigment. Ochronotic pigment was located among collagen fibres in articular cartilage, capsule and synovium. Pigment was absent in mineralised collagen fibres of bone. Schmorl's reagent demonstrated smaller amounts of pigment attached to the collagen fibres, undetected using H&E. Schmorl's staining of in vitro cultures revealed pigment deposits both intraand extracellularly. Ultrastructural examination of tissue samples revealed pigment deposition on collagen fibres in cartilage and capsule; in some regions pigment was easily identifiable bound to collagen, whereas others had no pigment. Ultrastructural distribution differed between capsule and cartilage. Pigment in capsule was associated with the collagen fibril periodicity and was also
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